Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Eckert

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
European Heart Journal|September 17, 1999
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT)A Kleemann, S Eckert, A von Eckardstein, et al.
Deutsche Medizinische Wochenschrift (1946)|December 1, 2007
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]S Eckert, E Erdmann, R Lundershausen, et al.
Blood|May 25, 1992
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemiaS Charache, G J Dover, R D Moore, et al.
AJNR. American Journal of Neuroradiology|August 9, 2020
Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple SclerosisE Ghione, N Bergsland, M G Dwyer, et al.
Schmerz (Berlin, Germany)|September 23, 2011
[Epidural spinal cord stimulation for therapy of chronic pain. Summary of the S3 guidelines]V Tronnier, R Baron, F Birklein, et al.
JAMA|June 22, 1999
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene EvaluationS R Cummings, S Eckert, K A Krueger, et al.
Deutsche Medizinische Wochenschrift (1946)|November 4, 2011
[Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment]F Mahfoud, O Vonend, H Bruck, et al.
JAMA|October 12, 1999
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsB Ettinger, D M Black, B H Mitlak, et al.
Journal of Periodontology|July 29, 2000
Re: A comparison of endosseous dental implant surfaces. Cochran DL (1999;70:1523-1539)T West, L Langer, S Karabin, et al.
Breast Cancer Research and Treatment|March 23, 2001
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluationJ A Cauley, L Norton, M E Lippman, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
European Heart Journal|September 17, 1999
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT)A Kleemann, S Eckert, A von Eckardstein, et al.
Deutsche Medizinische Wochenschrift (1946)|December 1, 2007
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]S Eckert, E Erdmann, R Lundershausen, et al.
Blood|May 25, 1992
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemiaS Charache, G J Dover, R D Moore, et al.
AJNR. American Journal of Neuroradiology|August 9, 2020
Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple SclerosisE Ghione, N Bergsland, M G Dwyer, et al.
Schmerz (Berlin, Germany)|September 23, 2011
[Epidural spinal cord stimulation for therapy of chronic pain. Summary of the S3 guidelines]V Tronnier, R Baron, F Birklein, et al.
JAMA|June 22, 1999
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene EvaluationS R Cummings, S Eckert, K A Krueger, et al.
Deutsche Medizinische Wochenschrift (1946)|November 4, 2011
[Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment]F Mahfoud, O Vonend, H Bruck, et al.
JAMA|October 12, 1999
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsB Ettinger, D M Black, B H Mitlak, et al.
Journal of Periodontology|July 29, 2000
Re: A comparison of endosseous dental implant surfaces. Cochran DL (1999;70:1523-1539)T West, L Langer, S Karabin, et al.
Breast Cancer Research and Treatment|March 23, 2001
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluationJ A Cauley, L Norton, M E Lippman, et al.
Pageof 13